MediPharm Labs Corp. (MEDIF)

Market Cap	21.72M
Revenue (ttm)	33.10M
Net Income (ttm)	-5.76M
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	96,429
Open	0.0507
Previous Close	0.0540
Day's Range	0.0507 - 0.0508
52-Week Range	0.0380 - 0.0850
Beta	0.71
RSI	54.82
Earnings Date	Mar 27, 2026

About MediPharm Labs

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, develops, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll canna...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 161
• Stock Exchange: OTCMKTS
• Ticker Symbol: MEDIF

Financial Performance

In 2024, MediPharm Labs's revenue was 41.96 million, an increase of 26.92% compared to the previous year's 33.06 million. Losses were -10.69 million, -18.26% less than in 2023.

Financial numbers in CAD